Articles

LIM-only protein FHL2 attenuates vascular tissue factor activity, inhibits thrombus formation in mice and FHL2 genetic variation associates with human venous thrombosis

The Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center (UMC), Leiden, the Netherlands
Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
Department of Molecular Cell Biology, Sanquin Research, Amsterdam, the Netherlands
Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht UMC, Maastricht, The Netherlands
Department of Molecular Cell Biology, Sanquin Research, Amsterdam, the Netherlands
Department of Molecular Cell Biology, Sanquin Research, Amsterdam, the Netherlands
Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht UMC, Maastricht, The Netherlands
Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA;Center for Thrombosis and Hemostasis Mainz, Germany
Department of Clinical Epidemiology, Leiden UMC, Leiden, the Netherlands
The Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center (UMC), Leiden, the Netherlands
Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands
Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands;Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands
Vol. 105 No. 6 (2020): June, 2020 https://doi.org/10.3324/haematol.2018.203026